Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Chartwell Pharmaceuticals LLC
FDA Inspection
•Chartwell Pharmaceuticals LLC•May 31, 2024

Chartwell Pharmaceuticals LLC – FDA Inspection, May 31, 2024

Record Details

This FDA Inspection record concerns Chartwell Pharmaceuticals LLC, with an inspection on May 31, 2024, issued by the New York District Office, covering human drugs.

Company
Chartwell Pharmaceuticals LLC
Inspection Date
May 31, 2024
Product Type
Human Drugs
Office
New York District Office
People
  • John D. McIntosh (Issuing Officer)
  • Josh Renzo N. Ramilo (Issuing Officer)
  • JoshRenzo N. Ramilo
  • Stephenie M. Ortiz (Investigator)
View Company Profile

ID · 3dfcf0f2-695e-4a28-bd9d-da2684dfb317

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1236033
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued, view the record

FDA Citations

5
  1. 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
  2. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  3. 21 CFR 211.160(b)(3)Drug products-sampling procedures/specifications
  4. 21 CFR 211.22(d)Procedures not in writing, fully followed
  5. 21 CFR 211.63Equipment Design, Size and Location

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Chartwell Pharmaceuticals LLC

8
DateClassificationOfficeProject area
November 18, 2025OAINew York District OfficeDrug Quality Assurance
December 19, 2024Not classifiedNew York District OfficeDrug Quality Assurance
April 8, 2024VAICenter for Drug Evaluation and ResearchBioresearch Monitoring
May 24, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 26, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Chartwell Pharmaceuticals LLC
  • FDA Inspection 1277530 - 2025-11-18
  • FDA Inspection 1257321 - 2024-12-19
  • FDA Inspection 1230475 - 2024-04-08
  • FDA Inspection 1206056 - 2023-05-24
  • FDA Inspection 1068395 - 2018-09-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chartwell Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.